Massachusetts General Hospital

Reporting of financial ties to industry has become an increasingly contentious, ethically murky area in both oncologic research and clinical practice.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

The FDA awarded 12 grants worth more than $15 million to fund clinical trials of medical products intended to treat patients with rare diseases.

Proton beam radiation therapy for breast cancer appeared safe and conferred similar rates of disease control compared with historical data of conventional radiation therapy, according to results of a prospective, single-arm phase 2 study published in Journal of Clinical Oncology.

The addition of veliparib to carboplatin and paclitaxel significantly improved PFS for patients with metastatic breast cancer who have germline BRCA mutations, according to randomized phase 3 study results presented at European Society for Medical Oncology Congress.

BARCELONA, Spain — Apalutamide with ongoing androgen deprivation therapy significantly improved OS compared with placebo among men with nonmetastatic, castration-resistant prostate cancer, according to updated results of the randomized phase 3 SPARTAN study presented at European Society for Medical Oncology Congress.

Advances in artificial intelligence technology and deep learning algorithms are leading the way to more timely and accurate cancer diagnoses, with the potential to improve patient outcomes.

Pediatricians can help parents quit smoking by routinely screening them for tobacco use and offering them cessation assistance during their child’s appointment, study findings published in JAMA Pediatrics suggest.

Olaparib in combination with temozolomide demonstrated promising clinical activity among patients with relapsed small cell lung cancer, according to results of a phase 1/phase 2 trial published in Cancer Discovery.

The U.S. Preventive Services Task Force reaffirmed its stance against pancreatic cancer screening for asymptomatic adults with no family history of the disease.